Literature DB >> 15288444

Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease.

Yifu Deng1, Beth Newman, Michael P Dunne, Peter A Silburn, George D Mellick.   

Abstract

Current opinion contends that complex interactions between genetic and environmental factors play a role in the etiology of Parkinson's disease (PD). Cigarette smoking is thought to reduce risk of PD, and emerging evidence suggests that genetic factors may modulate smoking's effect. We used a case-only design, an approach not previously used to study gene-environment interactions in PD, specifically to study interactions between glutathione-S-transferase (GST) gene polymorphisms and smoking in relation to PD. Four-hundred PD cases (age at onset: 60.0 +/- 10.7 years) were genotyped for common polymorphisms in GSTM1, P1, T1 and Z1 using well-established methods. Smoking exposure data were collected in face-to-face interviews. The independence of the studied GST genotypes and smoking exposure was confirmed by studying 402 healthy, aged individuals. No differences were observed in the distributions of GSTM1, T1 or Z1 polymorphisms between ever-smoked and never-smoked PD cases using logistic regression (all P > 0.43). However, GSTP1 *C haplotypes were over-represented among PD cases who ever smoked (odds ratio for interaction (ORi) = 2.00 (95% CI: 1.11-3.60, P = 0.03)). Analysis revealed that ORi between smoking and the GSTP1-114Val carrier status increased with increasing smoking dose (P = 0.02 for trend). These data suggest that one or more GSTP1 polymorphisms may interact with cigarette smoking to influence the risk for PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288444     DOI: 10.1016/j.neulet.2004.05.061

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Gene-gene interaction between tuberculosis candidate genes in a South African population.

Authors:  Erika de Wit; Lize van der Merwe; Paul D van Helden; Eileen G Hoal
Journal:  Mamm Genome       Date:  2010-08-27       Impact factor: 2.957

2.  Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.

Authors:  Amanda M Gleixner; Jessica M Posimo; Deepti B Pant; Matthew P Henderson; Rehana K Leak
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

3.  A novel approach to exploring potential interactions among single-nucleotide polymorphisms of inflammation genes in gliomagenesis: an exploratory case-only study.

Authors:  E Susan Amirian; Michael E Scheurer; Yanhong Liu; Anthony M D'Amelio; Richard S Houlston; Carol J Etzel; Sanjay Shete; Anthony J Swerdlow; Minouk J Schoemaker; Patricia A McKinney; Sarah J Fleming; Kenneth R Muir; Artitaya Lophatananon; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-01       Impact factor: 4.254

4.  Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease.

Authors:  Angelika D Wahner; Charles E Glatt; Jeff M Bronstein; Beate Ritz
Journal:  Neurosci Lett       Date:  2006-12-27       Impact factor: 3.046

5.  Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND.

Authors:  Hari Om Singh; Shruti D Marathe; Sumitra Nain; Dharmesh Samani; Vijay Nema; Manisha V Ghate; R R Gangakhedkar
Journal:  J Biosci       Date:  2017-09       Impact factor: 1.826

6.  Glutathione S-transferase T1 and M1 null genotypes and Parkinson's disease risk: evidence from an updated meta-analysis.

Authors:  Hongzhou Liu; Jie Peng; Jiajia Gao; Fang Zheng; Chaorong Tie
Journal:  Neurol Sci       Date:  2015-04-14       Impact factor: 3.307

7.  Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression.

Authors:  Min Shi; Joshua Bradner; Theo K Bammler; David L Eaton; Jianpeng Zhang; ZuCheng Ye; Angela M Wilson; Thomas J Montine; Catherine Pan; Jing Zhang
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

8.  Null genotype of GSTT1 contributes to increased Parkinson's disease risk in Caucasians: evidence from a meta-analysis.

Authors:  Dan Wang; Jun-Xia Zhai; Li-Mei Zhang; Dian-Wu Liu
Journal:  Mol Biol Rep       Date:  2014-08-03       Impact factor: 2.316

9.  Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione-S-transferase and DNA repair gene polymorphisms.

Authors:  Tommaso Cornetta; Clarice Patrono; Irene Terrenato; Francesca De Nigris; Anna Rita Bentivoglio; Antonella Testa; Valentina Palma; Tommaso Poggioli; Luca Padua; Renata Cozzi
Journal:  Cell Mol Neurobiol       Date:  2013-04-04       Impact factor: 5.046

10.  Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.

Authors:  H O Singh; S Lata; M Angadi; S Bapat; J Pawar; V Nema; M V Ghate; S Sahay; R R Gangakhedkar
Journal:  Pharmacogenomics J       Date:  2015-12-15       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.